Loading quotes...
Forecast
The analysts' average price target is €171.84 (+24.66%). The median is €175.86 (+27.57%).
| Buy |
22 |
| Hold |
9 |
| Sell |
2 |
News Go to news feed
Align Technology: weak Q3 outlook weighs on stock despite record sales
Align Technology reported adjusted earnings per share of $2.64 for Q2 and revenue increased to $1.06 billion on record sales of 691,800 Invisalign units. The Q3 outlook of $1.00–1.02 billion was below analysts' expectations, prompting a premarket drop in the stock. Also weighing on results were a decline in system and service revenue, a one‑time VAT charge in the UK and announced restructuring costs, while the share buyback program was raised to $400–500 million. » More on de.investing.com
Align Technology expands board and raises share buyback to $400–500 million
Align Technology appoints three independent directors with healthcare and technology experience to the board after talks with investor Elliott. The company increases its common stock repurchase program through 2026 to $400–500 million and, with the help of a global advisory firm, launches a strategic review of its business model, commercial execution and scalability. Management and Elliott view the measures as steps to strengthen strategy and create long‑term shareholder value. » More on de.investing.com
align technology stock falls after EU antitrust probe over possible market abuse
The European Commission is conducting an antitrust review of Align Technology and suspects the company of having abused its position as market leader in clear dental aligners. Following the review, the stock plunged. No further details about the investigation were provided. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 925.45m | 7.74% |
| Gross profit | 602.84m | 0.34% |
| Net profit | 94.89m | 10.25% |
| EBITDA | 79.33m | 56.33% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €9.8bn |
Number of shares | 71.04m |
52-week high/low | €178.93 - €116.25 |
| Dividends | No |
Beta | 1.67 |
P/E ratio | 26.82 |
PEG ratio | -9.36 |
P/B ratio | 2.61 |
P/S ratio | 2.65 |
Company profile
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
| Name | Align Technology |
| CEO | Joseph Hogan |
| Headquarters | Tempe,
az USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| IPO | 28/06/2023 |
| Employees | 20,435 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | ALGN |
London Stock Exchange | 0HCK.L |
Frankfurt | AFW.F |
Düsseldorf | AFW.DU |
London | 0HCK.L |
SIX | AFW.SW |
München | AFW.MU |
Wien | ALGN.VI |
Milan | 1ALGN.MI |